Eric Rovner, MD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    astellas
    Date added:
    Date updated:
    11/05/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Hologix
    Date added:
    Date updated:
    11/05/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Bluewind
    Date added:
    Date updated:
    11/05/2024
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Urovant
    Date added:
    Date updated:
    11/05/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Valencia
    Date added:
    Date updated:
    11/05/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Allergan
    Date added:
    Date updated:
    11/05/2024
  • Attribution:
    Self
    Type of financial relationship:
    Stock
    Ineligible company:
    NextMed
    Date added:
    Date updated:
    11/05/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Medtronics
    Date added:
    Date updated:
    11/05/2024
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    NIH/NIDDK
    Date added:
    Date updated:
    11/05/2024
Return to Contemporary Pharmacotherapy for OAB 2021: Monotherapy and Combined Pharmacotherapy to Optimize Treatment Webcast (2021)